The Impact of Systemic Calcified Atherosclerosis in Patients With Chronic Kidney Disease

References 

1. Whaley-Connell AT, Sowers JR, McFarlane SI, et al. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51:S21–S29(suppl 2)
2. McCullough PA. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens. 2004;13:591–600
   • MEDLINE
   • CrossRef
3. McCullough PA, Li S, Jurkovitz CT, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51:S38–S45(suppl 2)
   • Abstract
   • Full Text
   • Full-Text PDF (136 KB)
   • CrossRef
4. McCullough PA. Spectrum of cardiorenal disease. Int J Geriatric Cardiol. 2005;2:131–135
5. McCullough PA, Rocher LR. Statin therapy in renal disease: Harmful or protective. Curr Atheroscler Rep. 2007;9:18–24
   • MEDLINE
   • CrossRef
6. Hanzel GS, Downes M, McCullough PA. Editorial: Renal function after renal artery stenting. J Geriatr Cardiol. 2005;2:196–197
7. McCullough P. Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv. 2006;67:335–343
   • MEDLINE
   • CrossRef
8. McCullough PA. Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney Int Suppl. 2005;95:s51–s58